JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹16 Cr | ₹17 Cr | ₹20 Cr | ₹17 Cr | ₹17 Cr |
What is the latest Contingent Liabilities ratio of JENBURKT PHARMACEUTICALS ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹16 Cr |
Mar2024 | ₹17 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹17 Cr |
Mar2021 | ₹17 Cr |
How is Contingent Liabilities of JENBURKT PHARMACEUTICALS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹16 Cr | -0.45 | |
Mar2024 | ₹17 Cr | -15.25 | |
Mar2023 | ₹20 Cr | 17.75 | |
Mar2022 | ₹17 Cr | -0.19 | |
Mar2021 | ₹17 Cr | - |
Compare Contingent Liabilities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹554.4 Cr | -5.7% | -9.2% | 38.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -6% | -7.3% | -12% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -5.7% |
-9.2% |
38.6% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses